Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography

Clinical Rheumatology

Volumn 28, Issue 5, 2009, Pages 607-609

  Turgut, Burak ^a   Turkcuoglu, Peykan ^b   Serdar Koca, Süleyman ^a   Aydemir, Orhan ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Hydroxychloroquine retinopathy; Optical coherence tomography; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REMISSION; RETINA MACULOPATHY; RETINOPATHY; SCOTOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL FIELD;

ADULT; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; OPHTHALMOSCOPY; PIGMENTATION; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 64449087085     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1108-0     Document Type: Article

References (6)

1. Yam JC, Kwok AK (2006) Ocular toxicity of hydroxychloroquine. Hong Kong Med J 12:294-304
2. Wetterholm DH, Winter FC (1964) Histopathology of chloroquine retinal toxicity. Arch Ophthalmol 71:82-87
3. Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL (1991) Hydroxychloroquine retinopathy. Am J Ophthalmol 112:528-534
4. Easterbrook M (1993) The ocular safety of hydroxychloroquine. Semin Arthritis Rheum 23:62S-67S
5. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: A report by the American Academy of Ophthalmology. Ophthalmology 109:1377-1382
6. Rodriguez-Padilla JA, Hedges TR 3rd, Monson B et al (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775-780